A standardised framework for community health impact investments
A standardised framework gives decision-makers a consistent way to judge whether investments improve community health, strengthen services and remain worthwhile over time. Here, “investment” includes grant-funded prevention, workforce placements, shared research infrastructure, digital access programs and partnerships that connect clinical care with community needs. The aim is a transparent method for comparing evidence, value and equity while respecting important differences between initiatives.
Queensland programs often operate across municipal and regional boundaries, so a measure that works in inner-city Brisbane may reveal something different in Ipswich, Cairns or a remote community. Daily life shapes access: people may combine a GP appointment, pharmacy collection, public transport and a community group session, so travel time and digital access belong alongside clinical measures. A common framework can hold the core questions steady—Who was reached? What changed? For whom? At what cost?—while allowing each partnership to select locally meaningful indicators. Queensland’s mixed provider market, including public hospitals, community-controlled services, not-for-profit organisations and private allied health practices, makes common definitions especially valuable.
A useful framework combines a theory of change, a minimum outcome set, transparent costing and a clear evaluation design. It should distinguish outputs, such as clinics delivered or people trained, from outcomes, such as shorter waiting times, better symptom control or fewer avoidable admissions. It should also examine broader effects on families, carers, cultural safety, service capacity and the sustainability of the partnership.
For Australian decision-makers, the framework must accommodate Medicare, the Medicare Benefits Schedule, the Pharmaceutical Benefits Scheme and the division of responsibilities between Commonwealth and state governments. It should make room for lived-experience knowledge alongside clinical and economic evidence. A shared set of definitions, reporting periods and data-quality standards would let funders compare portfolios while giving local teams room to explain context, variation and unintended effects.
Why consistent evaluation matters
Without a shared approach, each project may report activity, reach or satisfaction in ways that cannot be compared. A crowded waiting room is an output; reduced crowding or better access is an outcome. Funding can then drift toward visible delivery metrics even when the intended health benefit is uncertain. Consistent evaluation links resources, activities and outcomes so that funders can ask whether a different approach should be scaled, adapted or stopped.
Brisbane Diamantina Health Partners already helps researchers and clinicians manage competing demands, as described in its guidance on clinical research balance. That same partnership discipline supports impact evaluation: research questions should be shaped with service users, data collection should fit clinical workflows, and findings should be able to inform practice. Evaluation becomes part of translation rather than a report produced after the work is finished.
Defining outcomes and attribution
The framework should use a small set of core domains: equitable reach, health and wellbeing, service performance, capacity and sustainability, and economic value. Each domain needs agreed definitions, a baseline, a target and a reporting date. Local measures can be added for priority areas such as cancer survivorship, chronic disease, mental health, maternal and child health, trauma care or clinical innovation. Community advisory panels should help decide which outcomes count and how results will be used.
Attribution must be described honestly. Randomised trials may suit some clinical questions, while complex community partnerships often depend on matched comparisons, interrupted time series, contribution analysis or detailed implementation evidence. The chosen method should match the intervention and available data, with limitations stated plainly. Wider contextual resources, including a non-Australian explainer on steroid treatment costs, can help teams examine how prescribing choices affect patients and budgets, but Australian evidence and local guidelines should guide decisions.
Governance, equity and Australian requirements
A framework is only credible when communities have a formal role in governance, not simply an invitation to comment. Aboriginal and Torres Strait Islander partners should be supported through appropriate cultural and data-governance processes, with paid participation and authority over how findings are communicated. In Brisbane, that may involve local Aboriginal organisations; across the state, it may require regional partnerships with community-controlled health services. Equity measures should examine who benefits, who is missing and whether access barriers are reduced.
Privacy and ethics need a dedicated place in the design. Depending on the data involved, teams may need approvals from a human research ethics committee, adherence to the Privacy Act 1988 and Queensland’s Health Records Act 2001, and agreements covering linkage, de-identification, retention and access. Governance for health data can be complex in Queensland because of jurisdictional responsibilities and the circumstances of small, remote or cross-border populations. A documented data-governance plan should identify the legal basis, risks and accountable data owner before collection begins.
A practical evaluation and funding checklist
Before release of funds, each investment should have a concise evaluation plan, a named accountable lead, baseline measures and a budget for evaluation and community participation. The network’s translation research funding can support applicants in clarifying the research question, partnership roles and translation pathway, while the framework should connect those plans to consistent reporting across the portfolio.
The following recommendations provide a workable minimum for Queensland partnerships:
- Establish a shared outcome set, then add a limited number of locally selected measures tied to community priorities.
- Co-design questions and indicators with consumers, carers, clinicians and community organisations, and budget for their time.
- Publish a simple theory of change and baseline before funds are committed, including what the programme is not expected to change.
- Choose an evaluation design that matches the intervention, and record plausible alternative explanations for observed change.
- Use one reporting template covering reach, outcomes, equity, costs, implementation and unintended effects.
- Agree at the outset how findings will be shared, how participant privacy will be protected and how benefits will be sustained.
A standard one-page summary can accompany the full report for each investment. It should show the decision requested, core results, confidence in the evidence, total costs and any material variation between population groups. Comparable summaries help a funder identify cross-portfolio patterns, while detailed appendices retain the nuance required by clinicians, communities and reviewers.
Turning evaluation into sustained action
The value of a common framework appears when findings return to practice. Research teams can use evaluation evidence to refine protocols; services can use it to redesign pathways; and communities can use it to press for improvements. Translation also needs protected resources, governance continuity and time for implementation. Otherwise, useful findings remain in publications or presentations without changing routine care.
The immediate action is to convene a cross-sector working group through Brisbane Diamantina Health Partners, bringing together community leaders, clinicians, researchers, Aboriginal health organisations, health-service managers and funders. Bring a proposed measure, partnership or pilot to the network, map it against the framework, establish the required governance, and begin a shared evaluation that can guide investment and improve health outcomes across Queensland.